EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Selective Modulation of Osteoclast Function by Bothrops moojeni Venom and Its Fractions: Implications for Therapeutic Targeting in Bone Diseases

Fernanda D'Amélio, Hugo Vigerelli iD, Isabel de Fátima Correia Batista iD, Rodrigo Pinheiro Araldi iD, Álvaro R B Prieto-da-Silva iD, Daniel Carvalho Pimenta iD, Irina Kerkis

Toxins · 2025

DOI: 10.3390/toxins17030141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Fernanda D'Amélio und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetics, Butantan Institute, São Paulo 05503-900, Brazil. Hauptthemen laut MEDLINE: Osteoclasts, Bothrops, Crotalid Venoms, Bone Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK, São Paulo Research Foundation (FAPESP—Fundação de Amparo à Pesquisa do Estado de São Paulo, São Paulo, SP, Brazil), GlaxoSmithKline and Butantan Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Our study explores the differential effects of Bothrops moojeni venom and its fractions on osteoclast (OC) morphology, function, and osteoclastogenesis. The crude venom and its high-molecular-weight (HMW) fraction disrupt critical OC processes, including F-actin ring formation and mitochondrial distribution, thereby impairing bone resorption. These components primarily target cytoskeletal integrity and transcription regulation, with the OBSCN gene playing a direct role in OC function. In contrast, the low-molecular-weight (LMW) fraction selectively modulates OCs without significant cytoskeletal alterations. It influences vital cellular signaling pathways, notably through FNIP1 and FNIP2, essential for OC differentiation and function. This suggests a more targeted therapeutic approach with potentially fewer off-target effects. The venom also alters cytokine production, increasing IL-6 and IL-10 levels. Elevated IL-6 levels promote osteoclastogenesis and bone resorption, while IL-10 appears to counterbalance these effects through a regulatory feedback mechanism. Secretome analysis reveals that the crude venom and HMW fraction disrupt proteins involved in membrane trafficking and structural integrity. In contrast, the LMW fraction influences matrix remodeling, energy metabolism, and gene regulation. Gene interaction analysis LMW fraction post-treatment identifies FNIP1 and FNIP2 as critical targets involved in osteoclastogenesis. The observed changes in gene expression, including those related to immune response, energy metabolism, and chromatin remodeling, provide insights into the venom’s impact on bone health. Overall, the LMW fraction shows promise for drug development due to its selective implications and potential for fewer side effects, offering a more precise approach to treating bone diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoclastsBothropsCrotalid VenomsBone DiseasesAnimalsMiceOsteogenesisCytokinesVenomous Snakes

Stichwörter der Autor:innen

Bothrops moojenifunctionhigh- and low-molecular-weight fractionmolecular targetsmorphologyosteoclastsecretome

Substanzen

Crotalid VenomsCytokines

Autor:innen und Institutionen

  • Laboratory of Genetics, Butantan Institute, São Paulo 05503-900, Brazil.
  • The Postgraduate Program in Toxinology, Butantan Institute, São Paulo 05503-900, Brazil.
  • Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, São Paulo 05503-900, Brazil.
  • Laboratory of Biochemistry and Biophysics, Butantan Institute, São Paulo 05503-900, Brazil.

ORCID-Profile: Hugo Vigerelli, Isabel de Fátima Correia Batista, Rodrigo Pinheiro Araldi, Álvaro R B Prieto-da-Silva, Daniel Carvalho Pimenta

Förderung

  • GSK
  • São Paulo Research Foundation (FAPESP—Fundação de Amparo à Pesquisa do Estado de São Paulo, São Paulo, SP, Brazil)
  • GlaxoSmithKline and Butantan Foundation

Zitieren

APA

D'Amélio, F., Vigerelli, H., Batista, I. F. C., Araldi, R. P., Prieto-da-Silva, Á. R. B., Pimenta, D. C., & Kerkis, I. (2025). Selective Modulation of Osteoclast Function by Bothrops moojeni Venom and Its Fractions: Implications for Therapeutic Targeting in Bone Diseases. Toxins. https://doi.org/10.3390/toxins17030141

Vancouver

D'Amélio F, Vigerelli H, Batista IFC, Araldi RP, Prieto-da-Silva ÁRB, Pimenta DC, et al. Selective Modulation of Osteoclast Function by Bothrops moojeni Venom and Its Fractions: Implications for Therapeutic Targeting in Bone Diseases. Toxins. 2025. doi:10.3390/toxins17030141

BibTeX
@article{DAmlio2025,
  author = {D'Amélio, Fernanda and Vigerelli, Hugo and Batista, Isabel de Fátima Correia and Araldi, Rodrigo Pinheiro and Prieto-da-Silva, Álvaro R B and Pimenta, Daniel Carvalho and Kerkis, Irina},
  title = {Selective Modulation of Osteoclast Function by Bothrops moojeni Venom and Its Fractions: Implications for Therapeutic Targeting in Bone Diseases},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins17030141}
}
Kostenlos starten →